Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
39 Cards in this Set
- Front
- Back
- 3rd side (hint)
Nephrotic Syndrome
--general clinical findings(3) |
1. Marked proteinuria (>3.5g)
2. Peripheral edema 3. Lipiduria, hyperlipidemia |
pg 16
|
|
Acute Nephritic Syndrome
--general clinical findings(3) |
1. Hematuria (gross or micro)
2. Proteinuria (mild to moderate) 3. HTN |
pg 16
|
|
Acute Renal Failure
--general clinical findings(3) |
1. Anuria/oliguria
2. Azotemia (abnormal levels of nitrogen-containing compounds -- urea, creatinine) 3. Acute onset -- days to weeks |
pg 16
|
|
Nephrotic Syndrome
--definition |
--defined by a urinary protein loss > 3.5g/24hr, resulting in hypoalbuminemia, peripheral edema, hyperlipidemia as well as an increased propensity for infection and hypercoaguability
|
pg 16
|
|
Nephrotic Syndrome
-differential diagnosis in children |
Primary Renal Disease (95%)
1. Minimal Change Disease (65%) 2. Focal Segmental Sclerosis (10%) 3. Membranoproliferative GN (10%) 4. Membranous GN (5%) Secondary Renal Disease (5%) 1. Uncommon in children -- SLE |
pg 16
|
|
Nephrotic Syndrome
-differential diagnosis in adults |
Primary Renal Disease (60%)
1. Focal Segmental Sclerosis (60%) 2. Membranous GN (33%) 3. Minimal Change Disease (15%) 4. IgA Nephropathy (9%) 5. Membranoproliferative GN (2%) 6. Other (6%) Secondary Renal Disease (40%) 1. DM 2. SLE 3. Amyloidosis |
pg 16
|
|
Minimal Change Disease
-epidemiology -pathogenesis |
--#1 cause of nephrotic syndrome in children
--Primary podocyte injury of unknown cause; perhaps due to a circulating, non-antibody, immune related substance --> reduction of poly-anionic components of GBM with loss of fixed (-) charges --> increased loss of small (-) charged proteins in urine (albumin) |
pg 16
|
|
Minimal Change Disease
-LM -IF -EM |
LM: NORMAL
IM: Negative EM: Diffuse podocyte foot process effacement (lose foot processes) -- no immune complexes are noted |
pg 16
|
|
Focal Segmental Glomerulosclerosis - primary
-epidemiology -pathogenesis |
--most common cause of nephrotic syndrome in AA, #2 in children
--strong evidence FSGS is caused by circulating factor that is not an antibody, but someway related to the immune system |
pg 16
|
|
Focal Segmental Glomerulosclerosis - primary
-LM -IF -EM |
LM: scattered glomeruli, less than 50% in early biopsies, show collapse of loops adjacent to the vascular pole with obliteration of capillary loops of that portion of the glomerulus w/scarring or sclerosis.
IF: negative EM: diffuse podocyte injury, as in minimal change disease, with effacement of foot processes, no immune deposition |
pg 17
|
|
Focal Segmental Glomerulosclerosis - secondary
-pathogenesis |
When the # of glomeruli are decreased due to developmental abnormalities or diseases, the remaining glomeruli become hypertrophic and there is an increase in glomerular blood pressureand filtration to compensate for the decreased number of nephrons --> damage to the glomerulus
|
pg 17
|
|
Focal Segmental Glomerulosclerosis - collapsing glomerulopathy
-epidemiology |
--Classical association with HIV infection, IV drug use and AA
--virulent, rapidly progressive disorder marked by massive proteinuria and end stage renal disease w/in 13 months |
pg 18
|
|
Focal Segmental Glomerulosclerosis - collapsing glomerulopathy
-LM -IF -EM |
LM: segmental, often global, collpase of glomerular tufts with prominent hypertrophy and injury of overlying podocytes
IF: negative EM: podocye foot process effacement |
pg 18
|
|
Membranous Glomerulopathy
-epidemiology -secondary causes (4) |
--most common cause of nephrotic syndrome in adult caucasians
--most cases (85%) in adults are idiopathic, but the remaining are: 1. Chronic infection -malaria, syphilis, hep B 2. Autoimmune disease - SLE, RA 3. Cancer - colon most common 4. Medication - Au, penicillamine, captopril |
pg 18/19
|
|
Membranous Glomerulopathy
-pathogenesis |
--immune complex mediated disease
--auto-antibodies react with podocyte cell surface antigens and activate compliment (c5-9) injuring the podocyte and adjacent GBM --> complexes are capped and shed into the subepithelial space and can be recognized on IF and EM --> GBM reacts to deposits by "growing up" b/t the deposits and eventually incorporating them into the GBM --> thickened GBM |
pg 19
|
|
Membranous Glomerulopathy
-LM -IF -EM |
LM: Diffuse, uniform thickening of GBM without an increase in cellularity
IF: Coarse, regular, granular staining of the GBM; usually with IgM and C3 EM: Inumerable, subepithelial, immune complex type, dense deposits with overlying foot process injury and effacement |
pg 19
|
|
Membranoproliferative GM -- type 1
-classification -when to suspect it |
While often listed as causing nephrotic syndrome, this disorder may be associated with asymptomatic hematuria/proteinuria, acute nephritic syndrome, or a mixed nephritic/nephrotic presentation
--suspect when patients with nephrotic range proteinuria (>3.5g) who also have large numbers of red cells in urinalysis or evidence of renal failure with an increase in creatinine |
pg 19
|
|
Membranoproliferative GM -- type 1
-epidemiology -pathogenesis |
--affects primarily children and young adults
--immune complex mediated disease, complexes are deposited in the mesangium and subendothelial space --> activates compliment --> attracts inflammatory cells --> injures endothelial cells and GBM |
pg19/20
|
|
Membranoproliferative GM -- type 1
-secondary causes (3) |
1. Chronic infection -- Hep B, Hep C, subacute bacterial endocarditis, deep visceral abscess
2. Immune disorders -- SLE, cryoglobulinemia 3. Malignancies -- "paraneoplastic syndrome |
pg 19
|
|
Membranoproliferative GM -- type 1
-LM -IF -EM |
LM: glomeruli are hypercellular, w/mesangial hypercellularity and endocapillary proliferation. GBM is mildly to markedly thickened.
IF: peripheral capillary loop and mesangial staining for IgG and C3 EM: subendothelial electron dense immune type deposits are seen in the subendothelial space. Mesangial cell interpositioning occurs with GBM reduplication. Deposits are also seen in the mesangium |
pg 19
|
|
Acute Nephritic Syndrome
--characterization of syndrome --most common cause |
--Characterized by hematuria (gross or microscopic); proteinuria (not usually in nephrotic range); HTN; and mild renal insufficiency -- mildly elevated serum Cr.
--usually caused by acute post-infectious GN; most commonly post-streptococcal GN |
pg 20
|
|
Acute nephritic syndrome -- Post-strep GN
-clinical factors |
1. abrupt onset, 1-3 weeks after throat infection or 3-6 weeks after skin infection
2. edema, HTN, hematuria, azotemia, mild proteinuria and oliguria 3. anti-Streptolysin O titers or titers of anti-DNAase B are helpful in diagnosing past strep pyogenes infection 4. early in the disease, complement levels (C3 and C4) are often prominently decreased |
pg 20
|
|
Acute nephritic syndrome -- Post-strep GN
-pathogenesis |
Immune complex mediated disease
--circulating immune complexes associated with the Streptococcal infection are deposited in the glomerulus, or circulating strep-antigens become planted in the glomerulus and antibodies bind to them |
pg 20
|
|
Acute nephritic syndrome -- Post-strep GN
-LM -IF -EM |
LM: almost all of the capillary loops appear to be occluded by inflammatory cells (PMNs and monocytes) -- referred to as diffuse endocapillary proliferation.
IF: large, "lumpy-bumpy" granular peripheral capillary loop deposits; usually of IgG, C3, C1q and C4 EM: large, randomly spaced, subepithelial humps of immune complex type dense deposits |
pg 21
|
|
Acute nephritic syndrome -- Lupus nephritis
-clinical manifestations (4) |
1. Nephrotic syndrome - secondary
2. Acute nephritic syndrome 3. Asymptomatic hematuria/proteinuria 4. Frank acute renal failure - due to severe glomerular damage Renal biopsy is usually required to gauge the activity of the inflammation and to quantify any chronic changes to the kidney |
pg 21
|
|
Acute nephritic syndrome -- Lupus nephritis
-proliferative changes |
--Mesangial proliferation - mesangial hypercellularity and increased matrix material
--Endocapillary proliferation - subendothelial deposits results in damage to the GBM - margination of cells within the capillary loops, necrosis and even rupture of the GBM may occur |
pg 21/22
|
|
Acute nephritic syndrome -- Lupus nephritis
-LM -IF -EM |
LM: mesangial hypercellularity, subendothelial deposits
IF: deposits positive for IgG, IgA, IgM, C3, and C1q -- "full house" effect EM: "fingerprint" substructure in the deposits |
pg 22
|
|
Acute nephritic syndrome -- Lupus nephritis
-membranous changes |
Patients may have antibodies against podocyte surface antigens and develop the subepithelial deposits of membranous GN -- similar to idiopathic membranous GN
|
pg 22
|
|
Asymptomatic Hematuria/Proteinuria -- IgA nephropathy (Berger's disease)
-epidemiology |
--most commonly affects children and young adults
--high incidence in southeast asians and native americans - most common primary GN in the world --often history of upper respiratory or GI infection, or some other inflamed mucosal surface |
pg 22
|
|
Asymptomatic Hematuria/Proteinuria -- IgA nephropathy (Berger's disease)
-clinical presentation |
Patients present with a history of intermittent macroscopic hematuria, or hematuria/proteinuria are noted ona routine urinalysis
|
pg 22
|
|
Asymptomatic Hematuria/Proteinuria -- IgA nephropathy (Berger's disease)
-diagnosis |
--mesangial deposition of complexes containing IgA and C3 on IF (no classical pathway components like C1q or C4).
|
pg 23
|
|
Asymptomatic Hematuria/Proteinuria -- Alports Disease
-clinical presentation |
Patients present with varying degrees of:
1. Hematuria: most common presenting syndrome, usually microscopic and present in early childhood 2. High frequency hearing loss 3. Various occular defects which lead to increasing myopia and other visual changes |
pg 23
|
|
Asymptomatic Hematuria/Proteinuria -- Alports Disease
-pathogenesis |
--hereditary defect in Type IV collagen production (a component of the GBM)
--affects structures in the glomerulus, cochlea of the ear and certain eye structures |
pg 23
|
|
Asymptomatic Hematuria/Proteinuria -- Alports Disease
-LM -IF -EM |
LM: findings are nonspecific - glomeruli may appear to be normal or undergoing scarring
IF: not an immune complex disease, so routine IF is negative -- can be detected using newer techniques involving specially obtained anti-sera to various isoform chains of type IV collagen EM: used to be the only method of diagnosis -- GBM is often thickened, characteristic lamellation or basket weave pattern. |
pg 23
|
|
Asymptomatic Hematuria/Proteinuria -- Thin basement membrane disease
-characterization of disease -diagnosis |
--inherited disease, characterized by a defect in the GBM
--patients exhibit hematuria and proteinuria that may only be picked up on a routine physical --most specific finding is abnormally thin GBM by EM (no other glomerular disease shares this characteristic) |
pg 23
|
|
Rapidly Progressive Glomerulonephritis (RPGN)
-definition |
-- may be caused by a number of different diseases which cause severe injury to the glomerulus
--histopathological hallmark is the crescent; a proliferation of cells within Bowman's space with resultant collapse of the glomerulus |
pg 24
|
|
Rapidly Progressive Glomerulonephritis (RPGN)
-- Type I - anti-GBM disease |
--may be associated with immune attack of the pulmonary capillary basement membrane with alveolar hemorrhage (Goodpasture's syndrome)
--antibodies to the GBM develop and damage the GBM severely --bright, linear fluorescence of GBM for IgG is diagnostic |
pg 24/25
|
|
Rapidly Progressive Glomerulonephritis (RPGN)
-- Type II - immune complex mediated disease |
--any number of immune complex mediated diseases may cause RPGN when especially severe (SLE, post-strep GN, membranoproliferative GN and IgA nephropathy)
--important to diagnose these entities with kidney biopsy to allow for immediate treatment |
pg 25
|
|
Rapidly Progressive Glomerulonephritis (RPGN)
-- Type III - Pauci-immune disease (non-immune deposit or NID) |
--defined by the lack of finding of immune complexes or anti-GBM antibodies by IF and EM
--presence of serum antibody, ANCA in >90& of patients --patients have circulating antibodies to components of the primary granules in neutrophils (myeloperoxidase and proteinase-3) |
pg 25
|